IL6 and cancer: We observed that the AP3S1 overexpression was positively associated with many malignant pathways in pan-cancer, such as IL6 JAK STAT3 signaling, IL2 STAT5 signaling, TGF BETA signaling, interferon gamma response, and interferon alpha response.